12 December 1997
Ann Transplant 1997; 2(4): 19-21 :: ID: 497332
The treatment of primary hepatic malignancy with total hepatectomy and liver transplantation remains a controversial issue. In the past liver transplantation has been attempted for all the different types of primary and metastatic tumor of the liver with the rationale that the removal of the entire organ in the absence of extrahepatic metastatic disease would have offered the best possible survival. It has since become clear that several factors play a role in the survival of these patients, some of which are still poorly understood.
Keywords: hepatocellular carcinoma, metastatic disease, Transplantation
11 Jan 2022 : Original articleEfficacy of Nitric Oxide-Releasing Nanofibers in Reducing Renal Ischemia-Reperfusion Injury in a Rat Model
Ann Transplant In Press; DOI: 10.12659/AOT.934800
Most Viewed Current Articles
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
22 Dec 2021 : Original articleComparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...
Ann Transplant 2021; 26:e934163
01 Dec 2021 : Original articleSolid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-S...
Ann Transplant 2021; 26:e934175